Literature DB >> 3936346

In vivo modulation of leukotaxis by non-steroidal anti-inflammatory drugs.

T Shimanuki, R M Nakamura, G S diZerega.   

Abstract

Since non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for inhibition of inflammation, an in vivo assay for leukotaxis would be of use in comparing the biological activity effects of the agents. Here, the effects of 4 different NSAIDs on in vivo leukocyte accumulation was determined by quantitating N-formyl-methionyl-leucylphenylalanine induced leukotaxis in the rabbit anterior eye chamber. New Zealand white female rabbits were treated for three days with the following regimens: ibuprofen or aspirin, 0.1, 1.0, 10.0 or 100.0 mg/kg/day, indomethacin or flurbiprofen, 0.01, 0.1, 1.0, or 10.0 mg/kg/day. Indomethacin and flurbiprofen significantly reduced leukotaxis in a dose of 10.0 mg/kg/day. Aspirin was associated with a weak inhibition of leukotaxis. Ibuprofen had biphasic effects, 1.0 mg/kg/day potentiated and 10 mg/kg/day inhibited leukotaxis, whereas leukocyte accumulation was uneffected by a high dose (100.0 mg/kg/day). These results suggest that modulation of leukotaxis by NSAIDs may reflect a differential dose-response sensitivity of lipoxygenase and cycloxygenase pathways.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936346     DOI: 10.1007/bf01966687

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  28 in total

1.  Action of nonsteroidal, anti-inflammatory drugs on human and rat peripheral leucocyte migration in vitro.

Authors:  K A Brown; A J Collins
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

2.  Control of vascular permeability by polymorphonuclear leukocytes in inflammation.

Authors:  C V Wedmore; T J Williams
Journal:  Nature       Date:  1981-02-19       Impact factor: 49.962

3.  Anti-inflammatory drugs, prostaglandins and leucocyte migration.

Authors:  J R Walker; M J Smith; A W Ford-Hutchinson
Journal:  Agents Actions       Date:  1976-09

4.  Chemotactic response to some arachidonic acid lipoxygenase products in the rabbit eye.

Authors:  P Bhattacherjee; B Hammond; J A Salmon; R Stepney; K E Eakins
Journal:  Eur J Pharmacol       Date:  1981-07-17       Impact factor: 4.432

5.  Demonstration of inflammatory mediator-induced inflammation and endothelial cell damage in the anterior segment of the eye.

Authors:  F N Rowland; M J Donovan; M Lindsay; W I Weiss; J O'Rourke; D L Kreutzer
Journal:  Am J Pathol       Date:  1983-01       Impact factor: 4.307

6.  Calcium ionophore A23187 induces release of chemokinetic and aggregating factors from polymorphonuclear leucocytes.

Authors:  M A Bray; A W Ford-Hutchinson; M E Shipley; M J Smith
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

7.  The effects of some antirheumatic drugs on an in vitro model of human polymorphonuclear leucocyte chemokinesis.

Authors:  M J Smith; J R Walker
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

8.  Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils.

Authors:  E A Ham; D D Soderman; M E Zanetti; H W Dougherty; E McCauley; F A Kuehl
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

9.  Modulation of leukotaxis by ibuprofen. A quantitative determination in vivo.

Authors:  T Shimanuki; R M Nakamura; G S Dizerega
Journal:  Inflammation       Date:  1985-09       Impact factor: 4.092

10.  The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.

Authors:  H J Showell; R J Freer; S H Zigmond; E Schiffmann; S Aswanikumar; B Corcoran; E L Becker
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Use of modulators of airways inflammation in patients with CF.

Authors:  Clement L Ren
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

2.  Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain.

Authors:  S-H Choi; S Aid; U Choi; F Bosetti
Journal:  Pharmacogenomics J       Date:  2009-12-29       Impact factor: 3.550

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.